-

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on November 3, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1737984&tp_key=fe2490eae4 and will be archived online and available through February 3, 2026. To join via telephone, listeners may dial (201) 389-0879.

A telephonic playback will be available from 8:30 p.m. ET, November 3, 2025, through November 10, 2025. Participants can dial (412) 317-6671 and enter access code 13756407 to hear the playback.

About Medifast®:

Medifast (NYSE: MED) is the health and wellness company offering a simple, yet comprehensive approach to weight management and lifestyle change through its science-backed and coach-guided lifestyle system. Designed to address the challenges of metabolic dysfunction, the company’s lifestyle system integrates personalized plans, scientifically developed products and a framework for habit creation — all supported by a unique network of independent coaches. Science is core to the company, marked by an in-house Scientific & Clinical Affairs team and independent esteemed Scientific Advisory Board, 30+ research studies, 70+ scientific abstract presentations and publications, and 30+ publications in peer-reviewed scientific journals. With more than 40 years of clinical heritage, Medifast is addressing the metabolic health crisis through cutting-edge science and community-driven support and remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature®. For more information visit MedifastInc.com and follow Medifast on X and LinkedIn.

MED-F

Contacts

Investor Contact:
Medifast, Inc.
Steven Zenker
InvestorRelations@medifastinc.com
(443) 379-5256

Medifast

NYSE:MED

Release Versions

Contacts

Investor Contact:
Medifast, Inc.
Steven Zenker
InvestorRelations@medifastinc.com
(443) 379-5256

More News From Medifast

Medifast Announces Second Quarter 2026 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 Revenue: $76.4 million, with revenue per active earning coach of $6,529 Independent active earning coaches of 11,700 Net loss of $3.1 million or $0.28 loss per diluted share ("EPS") Cash, Cash Equivalents, and Investment Securities of $169.8 million wit...

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended June 30, 2026 on Monday, August 3, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The...

Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced the launch of Trilivy, a comprehensive metabolic health system uniquely designed to support healthy lifestyle change. The launch also introduces newly formulated meal replacements, including the Trilivy Reset Fueling line enhanced with MetaVantage Technology™, a platform of proprietary ingredient formulas intended to optimize metabolism by unlocking key metabolic pathways. The launch of Trilivy marks a major corporate transf...
Back to Newsroom